Science leads weekly startup funding rounds with $400 million neurotech raise

Science leads weekly startup funding rounds with $400 million neurotech raise
Neurotech startup tops funding

Venture funding remains active for technology startups this week despite a sharp pullback in publicly traded tech stocks that could weigh on private market sentiment if it continues. U.S. companies account for most of the largest disclosed rounds, while UK-based Isomorphic Labs secures the biggest financing overall with a $5 billion raise.

Highlights

  • Science secures $400 million Series D funding, boosting total to more than $900 million and making it the largest U.S. funding round of the week.
  • Model ML raises $250 million Series B at a $1.5 billion valuation, while Galvanize Therapeutics, General Flash, and Ramon.Space each raise more than $120 million.
  • London-based Isomorphic Labs secures the largest global round with $5 billion Series C, highlighting sustained investor interest in AI-driven drug discovery.

Largest rounds span neurotech, AI and biotech

As reported by Crunchbase News, brain-computer interface startup Science tops the week's U.S. funding rounds after securing $400 million in Series D financing, lifting its total funding to more than $900 million. The Alameda, California-based company focuses on brain-computer interface technology and neural engineering.

Model ML follows with a $250 million Series B round at a $1.5 billion valuation. The New York and London-based company, which builds an AI platform for financial and professional services, sees General Atlantic and QED Investors lead the financing.

Other large U.S. rounds include Galvanize Therapeutics with $130 million in Series D funding, General Flash with $128 million across seed and Series A rounds, and Ramon.Space with $124 million in Series B financing. Marrow Therapeutics also launches with a combined $173 million across Series A and B, including a $120 million Series B round, while Noeri debuts with $110 million in initial funding and Seawolf Therapeutics says it has raised $100 million to date.

BrightAI adds $97 million in new funding for its platform serving infrastructure-heavy industries, and Vincue closes on $93 million in growth capital. The list highlights continued investor appetite for AI, biotech, space technology, critical metals and industrial technology businesses.

Market backdrop and overseas activity

The funding announcements come during a volatile week for the broader technology market, with startup exits also drawing attention after Anthropic completes a major IPO. The weaker tone in listed tech shares raises the risk that negative sentiment could extend into private markets if the downturn persists.

Outside the U.S., London-based Isomorphic Labs lands the week's largest financing with a $5 billion Series C round led by Greenoaks and Sequoia Capital. The AI drug discovery startup, which also has offices in Massachusetts and Switzerland, underscores how large-scale capital continues to flow to companies at the intersection of artificial intelligence and life sciences.

We have also discussed the broader context around startup funding highlights spanning space tech, AI, industrial automation and wellness in a Crunchbase roundup.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.